Proteomic and metabolomic investigation of serum lactate dehydrogenase elevation in COVID-19 patients.

导出 OA

翻译打印收藏纠错

作者： Haixi,Yan ^[1] ; Xiao,Liang ^[2] ; Juping,Du ^[3] ; Zebao,He ^[4] ; Yu,Wang ^[1] ; Mengge,Lyu ^[1] ; Liang,Yue ^[5] ; Fangfei,Zhang ^[2] ; Zhangzhi,Xue ^[3] ; Luang,Xu ^[4] ; Guan,Ruan ^[2] ; Jun,Li ^[3] ; Hongguo,Zhu ^[4] ; Jiaqin,Xu ^[2] ; Shiyong,Chen ^[3] ; Chao,Zhang ^[4] ; Dongqing,Lv ^[2] ; Zongmei,Lin ^[3] ; Bo,Shen ^[4] ; Yi,Zhu ^[2] ; Biyun,Qian ^[3] ; Haixiao,Chen ^[4] ; Tiannan,Guo ^[6]

作者单位： Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical University, Linhai, China. ^[1] Key Laboratory of Structural Biology of Zhejiang Province, School of Life Sciences, Westlake University, Hangzhou, China. ^[2] Center for Infectious Disease Research, Westlake Laboratory of Life Sciences and Biomedicine, Hangzhou, China. ^[3] Institute of Basic Medical Sciences, Westlake Institute for Advanced Study, Hangzhou, China. ^[4] Shanghai Tongren Hospital and Clinical Research Institute, Hongqiao International Institute of Medicine, Shanghai Jiao Tong University School of Medicine, Shanghai, China. ^[5] Westlake Omics (Hangzhou) Biotechnology Co., Ltd. No.1, Hangzhou, China. ^[6]

关键词 COVID-19 biomarker lactate dehydrogenase metabolomics prognosis proteomics